{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-091486","form_type":"8-K","ticker":"ALHC","cik":"0001832466","company_name":"Alignment Healthcare, Inc.","filed_at":"2026-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.438357+00:00","generated_at":"2026-05-15T21:47:36.189455+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Selling stockholder sells 13.2M shares of Alignment Healthcare in underwritten offering via J.P. Morgan","bullets":["Selling Stockholder sold 13,167,733 shares of common stock via J.P. Morgan Securities LLC.","Offering closed March 4, 2026; company will not receive any proceeds from the sale.","Shares offered under automatically effective Registration Statement on Form S-3ASR filed March 2, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-091486","json":"https://secwatch.observer/filing/0001193125-26-091486.json","markdown":"https://secwatch.observer/filing/0001193125-26-091486.md","text":"https://secwatch.observer/filing/0001193125-26-091486.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832466/000119312526091486/0001193125-26-091486-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832466/000119312526091486/d46464d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:47:36.189455+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0b70884423e62c633ab170bd3240fda28175f4aa","claim":"Alignment Healthcare, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC and the selling stockholder listed on Schedule II thereto (effective 2026-03-02).","evidence_excerpt":"On March 2, 2026, Alignment Healthcare, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC (the “Underwriter”) and the selling stockholder listed on Schedule II thereto (the “Selling Stockholder”) with respect to an underwritten offering by the Selling Stockholder of 13,167,733 shares (the “Shares”) of the Company’s common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832466/000119312526091486/0001193125-26-091486-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"J.P. Morgan Securities LLC and the selling stockholder listed on Schedule II thereto"},{"label":"Effective","value":"2026-03-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}